Picture of Xvivo Perfusion AB logo

XVIVO — Xvivo Perfusion AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Brief: Xvivo Perfusion Q4 Reported EBITDA Falls To SEK 8.5 Million

Jan 30 (Reuters) - Xvivo Perfusion AB  XVIVO.ST :
    * A HISTORIC YEAR ENDED WITH A QUARTER OF SALES RECORDS
    * Q4 NET SALES OF NON-DURABLE GOODS IN QUARTER AMOUNTED TO
SEK
59.4 (52.3) MILLION
    * Q4 REPORTED EBITDA AMOUNTED TO SEK 8.5 (10.5) MILLION,
CORRESPONDING TO AN EBITDA MARGIN OF 14 PERCENT (18)

Source text for Eikon:  ID:nWkrbwjC83 
Further company coverage:  XVIVO.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Xvivo Perfusion AB

See all news